MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2 | -100.0% | 68 | -82.9% | 0.00% | – |
| Q2 2022 | $7,000 | -30.0% | 398 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -9.1% | 398 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -15.4% | 398 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | +8.3% | 398 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | 0.0% | 398 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | +500.0% | 398 | +696.0% | 0.00% | – |
| Q3 2018 | $2,000 | -100.0% | 50 | -100.0% | 0.00% | -100.0% |
| Q2 2016 | $6,182,000 | +24.5% | 202,035 | +52.3% | 0.03% | +21.4% |
| Q1 2016 | $4,965,000 | +339.8% | 132,645 | +299.3% | 0.03% | +366.7% |
| Q2 2015 | $1,129,000 | -3.9% | 33,217 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $1,175,000 | +28.3% | 33,217 | +23.5% | 0.01% | +20.0% |
| Q4 2014 | $916,000 | +740.4% | 26,900 | +740.6% | 0.01% | +400.0% |
| Q1 2014 | $109,000 | -98.3% | 3,200 | -98.9% | 0.00% | -97.8% |
| Q4 2013 | $6,294,000 | +31.2% | 300,000 | +68.0% | 0.04% | +4.7% |
| Q2 2013 | $4,798,000 | – | 178,574 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 5,809,799 | $205,667,000 | 4.45% |
| Tieton Capital Management, LLC | 146,650 | $5,191,000 | 3.90% |
| KESTREL INVESTMENT MANAGEMENT CORP | 614,275 | $21,745,000 | 2.97% |
| Provident Investment Management, Inc. | 375,032 | $13,276,000 | 2.70% |
| Summit Street Capital Management, LLC | 77,810 | $2,754,000 | 2.46% |
| RATIONAL ADVISORS LLC | 253,200 | $8,963,000 | 2.17% |
| S&T BANK/PA | 393,446 | $13,928,000 | 2.08% |
| Euclidean Technologies Management, LLC | 63,684 | $2,254,000 | 2.05% |
| Grace Capital | 220,769 | $7,815,000 | 1.76% |
| AIMZ Investment Advisors, LLC | 57,850 | $2,048,000 | 1.75% |